Clinical Trial Update: Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 Therapies [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and quality of life of trastuzumab with lapatinib or chemotherapy in metastatic, HER2-positive breast cancer patients refractory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Consorzio Oncotech | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN